OPRX$9.663.54%0.33
Optimizerx Corp (OPRX)
Date: 2026-11-04 16:00O: 9.49H: 9.90L: 9.48C: 9.90Vol: 73.43k
Optimizerx Corp stock is traded at $9.66, with a volume of 26,956. It is up +3.54% in the last 24 hours and up +12.72% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
Previous Close:
$9.33
Open:
$9.49
24h Volume:
26,956
Relative Volume:
0.22
Market Cap:
$181.96M
Revenue:
$107.35M
Net Income/Loss:
$6.84M
P/E Ratio:
27.35
EPS:
$0.3532
Net Cash Flow:
$14.64M
1W Performance:
+3.87%
1M Performance:
+12.72%
6M Performance:
+42.69%
1Y Performance:
-48.56%
1-Day Range:
$9.48$9.82
1-Week Range:
$9.00$9.64
52-Week Range:
$4.54$21.09
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx CorpSector
HealthcareIndustry
Health Information ServicesPhone
248-651-6558Address
260 CHARLES STREET, WALTHAM, MI, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
Optimizerx Corp Stock (OPRX) Financials Data
Optimizerx Corp Stock (OPRX) Insider Trading
- Stelmakh EdwardDec 19 '25Chief Finance & Strat Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 5,237
- Value ($)
- 0
- #Shares Total
- 128,218
- Stelmakh EdwardDec 19 '25Chief Finance & Strat Officer
- Transaction
- Sale
- Cost
- $13.51
- #Shares
- 1,388
- Value ($)
- 18,752
- #Shares Total
- 126,830
- Silvestro Stephen LDec 19 '25Chief Executive Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 6,546
- Value ($)
- 0
- #Shares Total
- 195,462
- Odence-Ford MarionDec 19 '25Chief Legal & Admin Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 3,928
- Value ($)
- 0
- #Shares Total
- 94,526
- Besch DougDec 19 '25Chief Product & Tech Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 1,964
- Value ($)
- 0
- #Shares Total
- 71,536
- Silvestro Stephen LOct 03 '25Chief Executive Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 6,649
- Value ($)
- 0
- #Shares Total
- 190,536
- Stelmakh EdwardOct 03 '25Chief Finance & Strat Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 16,623
- Value ($)
- 0
- #Shares Total
- 127,387
- Besch DougOct 03 '25Chief Product & Tech Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 3,325
- Value ($)
- 0
- #Shares Total
- 70,555
- Silvestro Stephen LOct 03 '25Chief Executive Officer
- Transaction
- Sale
- Cost
- $18.75
- #Shares
- 1,620
- Value ($)
- 30,375
- #Shares Total
- 188,916
- Odence-Ford MarionOct 03 '25Chief Legal & Admin Officer
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 6,649
- Value ($)
- 0
- #Shares Total
- 92,550
Optimizerx Corp Stock (OPRX) Latest News
One manager reports sole voting power over 1.32M OptimizeRx (OPRX) shares held by clients. - Stock Titan
Oct 21, 2026Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com Canada
Oct 02, 2026Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com UK
Oct 02, 2026Stock vesting triggers tax withholding at OptimizeRx (OPRX): 414 shares at $8.39 each. - Stock Titan
Oct 02, 2026Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com Nigeria
Oct 02, 2026Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com India
Oct 02, 2026Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars? - Zacks Investment Research
Sep 23, 2026OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath - Stock Titan
Sep 22, 2026Optimizerx stock edges lower as investors digest recent results - AD HOC NEWS
Sep 20, 2026OptimizeRx stock gains guidance clarity after Q2 2026 results - AD HOC NEWS
Sep 19, 2026OPRX 8-K Filings - OptimizeRx Corporation SEC 8-K - Stock Titan
Sep 18, 2026OptimizeRx Corporation - Common Stock (Nasdaq:OPRX) Detailed Stock Data - The Chronicle-Journal
Sep 18, 2026
Sep 17, 2026
